Match tier Confirmed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Àlex Soriano

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Jefe de Servicio

79 h-index 699 pubs 26,088 cited

  • Humans
  • Male
  • Female
  • Aged
  • Middle Aged
  • Anti-Bacterial Agents
  • Prosthesis-Related Infections
  • Adult
  • Retrospective Studies
  • Aged, 80 and over
  • Treatment Outcome
  • Bacteremia
  • COVID-19
  • Prospective Studies
  • Staphylococcal Infections

Biography and Research Information

OverviewAI-generated summary

Àlex Soriano's research focuses on microbial infections and disease, with a significant emphasis on SARS-CoV-2 and COVID-19. Soriano has investigated the incidence of co-infections and superinfections in hospitalized COVID-19 patients through retrospective cohort studies. Further work includes examining the association between IL-6 antagonists and mortality among hospitalized COVID-19 patients and analyzing the clinical features, ventilatory management, and outcomes of ARDS caused by COVID-19, comparing them to other causes of ARDS. The researcher has also studied the spread of SARS-CoV-2 variants and explored COVID-19 in patients with HIV through clinical case series. Additionally, Soriano's work has extended to the influence of vancomycin minimum inhibitory concentration on treating methicillin-resistant Staphylococcus aureus bacteremia and has contributed to defining periprosthetic joint infection through the EBJIS definition. Soriano's research activities are supported by a substantial publication record, with 699 total publications and 26,088 total citations, contributing to an h-index of 79.

Metrics

  • h-index: 79
  • Publications: 699
  • Citations: 26,088

Positions

  • Jefe de Servicio 2016–present
    Hospital Clínic de Barcelona Servicio de Enfermedades Infecciosas ORCID
  • Jefe de Servicio
    University of Arkansas for Medical Sciences ORCID

Selected Publications

  • Debridement, antimicrobial therapy, and implant retention (DAIR) as curative strategy for acute periprosthetic hip and knee infections: a position paper of the European Bone & Joint Infection Society (EBJIS) (2025)
    Journal of Bone and Joint Infection 29 citations DOI OpenAlex
  • Effectiveness and safety of cefiderocol treatment in patients with Gram-negative bacterial infections in Spain in the early access programme: results of the PERSEUS study (2025)
    19 citations DOI OpenAlex
  • Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis (2024)
    Microbiology Spectrum 31 citations DOI OpenAlex
  • Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022 (2024)
    Journal of Global Antimicrobial Resistance 107 citations DOI OpenAlex
  • Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial (2024)
    The Lancet Infectious Diseases 91 citations DOI OpenAlex
  • Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials (2023)
    The Lancet Infectious Diseases 80 citations DOI OpenAlex
  • Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial (2023)
    Nature Medicine 47 citations DOI OpenAlex
  • A second update on mapping the human genetic architecture of COVID-19 (2023)
    Nature 124 citations DOI OpenAlex
  • Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel (2023)
    International Journal of Antimicrobial Agents 58 citations DOI OpenAlex
  • Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic (2023)
    Open Forum Infectious Diseases 33 citations DOI OpenAlex
  • High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations (2023)
    22 citations DOI OpenAlex
  • Invasive candidiasis: current clinical challenges and unmet needs in adult populations (2023)
    Journal of Antimicrobial Chemotherapy 187 citations DOI OpenAlex
  • Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study (2023)
    Journal of Infection 73 citations DOI OpenAlex
  • Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial (2023)
    The Lancet Regional Health - Europe 32 citations DOI OpenAlex
  • Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series (2023)
    22 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

1509 Collaborators 501 Institutions 50 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics